Endometrial Carcinoma: Immune Microenvironment and Emerging Treatments in Immuno-Oncology
Endometrial cancer (EC) can easily be cured when diagnosed at an early stage. However, advanced and metastatic EC is a common disease, affecting more than 15,000 patients per year in the United Sates. Only limited treatment options were available until recently, with a taxane–platinum combination as...
Main Authors: | Sandrine Rousset-Rouviere, Philippe Rochigneux, Anne-Sophie Chrétien, Stéphane Fattori, Laurent Gorvel, Magali Provansal, Eric Lambaudie, Daniel Olive, Renaud Sabatier |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/6/632 |
Similar Items
-
Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies)
by: Ruriko Ono, et al.
Published: (2019-07-01) -
Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial Cancer
by: Neal C. Ramchander, et al.
Published: (2020-01-01) -
Endometrial Tumor Microenvironment Alters Human NK Cell Recruitment, and Resident NK Cell Phenotype and Function
by: Clara Degos, et al.
Published: (2019-04-01) -
Predictive and Prognostic Value of Microsatellite Instability in Gynecologic Cancer (Endometrial and Ovarian)
by: Camille Evrard, et al.
Published: (2021-05-01) -
Multi-omics profiling reveals distinct microenvironment characterization of endometrial cancer
by: Yixuan Cai, et al.
Published: (2019-10-01)